Zhejiang Xinguang Pharmaceutical Co Ltd (300519.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000027T3

Price
14.67 CNY
Market cap
2.35 bn CNY
P/E (2025)
43.30
P/S (2025)
8.85
Dividend yield
2.04 %
Net margin
20.43 %
Return on equity (ROE)
6.48 %
Return on assets (ROA)
6.10 %

Zhejiang Xinguang Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue267.66 m CNY265.36 m CNY
Gross profit89.77 m CNY102.86 m CNY
Operating income57.35 m CNY48.36 m CNY
EBIT57.02 m CNY48.36 m CNY
Net income50.39 m CNY54.21 m CNY
Diluted EPS – continuing operations0.31 CNY0.34 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Zhejiang Xinguang Pharmaceutical Co Ltd

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers Chinese patent medicines, chemical medicines, and health food in various forms, including tablets, mixtures, granules, syrups, powders, hard capsules, and oral liquids, as well as drinks. Its products are used for the treatment of cardiovascular, trauma, respiratory, digestive, urinary, pediatric, and immunity diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.